Clinical Trials Logo

Clinical Trial Summary

Alzheimer's disease (AD) is characterised by a progressive loss of memory and cognitive function. In the early stages of AD, there is a progressive accumulation of molecules: β-amyloid peptides (Aβ) in the brain. There is a link between the accumulation of Aβ peptides and the deterioration of sleep, but current knowledge does not confirmed this link. The objective of this study is to define whether there is a link between cognitive decline and sleep disorders. If a correlation is found, this could allow earlier treatment of sleep disorders in the longer term in order to slow the development of AD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05629871
Study type Interventional
Source University Hospital, Montpellier
Contact Claire Denis
Phone +33467333162
Email claire-denis@chu-montpellier.fr
Status Recruiting
Phase N/A
Start date April 17, 2023
Completion date July 1, 2027

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Active, not recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Completed NCT02778321 - Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction N/A
Recruiting NCT05300113 - Artificial Intelligence Neuropathologist
Recruiting NCT05016700 - Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders
Completed NCT02767583 - Assessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese Patients N/A
Recruiting NCT06365658 - Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective
Not yet recruiting NCT05649514 - Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease N/A